ESPERITE N.V. announces that due to sanitary constraints the Extraordinary General Meeting of Shareholders scheduled on 30 September 2020 will be organized by audio and video conference.

September 18, 2020 Group News , Press Release (ENG)
Financial and business update

Esperite announces the EGM by audio and video conference

The Netherlands – 18 September 2020

 

Esperite N.V. (Euronext: ESP, “Esperite” or the “Company”) announces that due to sanitary constraints the Extraordinary General Meeting of Shareholders (“EGM”) to be held on 30 September 2020 at 14:00 CEST will be organized by audio and video conference.

 

As at the date hereof, the Company has an issued and outstanding share capital of EUR 7,724,754.80 comprising 77,247,548 ordinary shares with a nominal value of EUR 0.10 each and 31 sub-shares with a nominal value of EUR 0.02 each.

 

The notice, the complete agenda and the explanatory notes thereto and the minutes referred to in agenda item 2 are available for inspection and can be acquired at no costs at the registered office of the Company (Vosselmanstraat 1, 7311 CL Apeldoorn). These documents can also be downloaded from the website of the Company (www.esperite.com).

 

Registration Date

Holders of shares or other persons with voting and/or meeting rights who are registered on 2 September 2020 (the “Registration Date”), after processing all additions and withdrawals as at the Registration Date, in the Company’s shareholders’ register or in the administration held by the Intermediaries with Euroclear Nederland within the meaning of the Securities Giro Act (Wet Giraal Effectenverkeer), will have the right to attend the meeting in person or by proxy. Only shareholders may vote at the EGM.

 

Notification

Shareholders who wish to attend the EGM, by audio and video conference, must notify the Company’s agent Van Lanschot Kempen Wealth Management N.V.

in writing (Van Lanschot Kempen Wealth Management N.V., Agency Services department, Beethovenstraat 300, 1077 WZ Amsterdam or by facsimile: +31(0)203489549 or by e-mail: proxyvoting@kempen.nl) ultimately by 17.00 hours CEST on 25 September 2020. The registration certificate issued by Van Lanschot Kempen Wealth Management N.V. serves as admission ticket for the meeting.

Shareholders must communicate their contact details, email address and phone number, in order to receive their personal access codes to the meeting.

Shareholders will ask questions at the end of the EGM, using the “raise hand” function.

 

Proxy and Voting procedure

Due to the exceptional circumstances, shareholders must submit their votes using the proxy form register in accordance with the procedure stated above and deposit a written power of attorney which must be received by Van Lanschot Kempen Wealth Management N.V. in writing (Van Lanschot Kempen Wealth Management N.V.

, Agency Services department, Beethovenstraat 300, 1077 WZ Amsterdam or by facsimile: +31(0)203489549 or by e-mail: proxyvoting@kempen.nl) no later than 17.00 hours CEST on 25 September 2020.

Please note that when using sub-proxies, all proxies that are part of the proxy-chain need to be provided in time. A power of attorney and voting instruction form for this purpose can be obtained via our website.

 

Registration and identification

Registration for admission to the electronic waiting room to the remote EGM will take start one hour prior to the commencement of the meeting. After this time registration is no longer possible. Persons entitled to attend remotely the EGM may be asked for identification prior to being admitted and are therefore requested to be prepared to justify their identity.

 

The EGM’s convocation notice, agenda and the explanatory notes to the agenda and further EGM materials can be downloaded from Esperite’s website (www.esperite.com) and are available free of charge at the registered office of Esperite (Vosselmanstraat 1, 7311 CL Apeldoorn).

 

***

About ESPERITE

ESPERITE is a diversified investment company group. Established in 2000, Esperite is a holding company, listed at Euronext Amsterdam and Paris. ESPERITE invests in companies able to transform the power of state-of-the-art technologies and scientific advancements into high quality products.

To learn more about the ESPERITE Group, or to book an interview with the CEO Frederic Amar: info@esperitegroup.com or visit the websites at www.esperite.com

 ***

read more

ESPERITE : Extraordinary General Meeting of Shareholders 26 March 2020

February 13, 2020 Group News , Press Release (ENG)

ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders on 26 March 2020

Amsterdam, The Netherlands – 13 February 2020

***

PDF Downloads – EGM 26 March 2020

           Press Release :  EGM-26-March-2020-Press-Release-1.pdf

          Agenda  :              EGM-26-March-2020-Agenda-1.pdf

          Notice  :                EGM-26-March-2020-Notice-1.pdf

Explanatory Notes :   EGM-26-March-2020-Explanatory-Notes-1.pdf

Power of Attorney :    EGM-26-March-2020-Power-of-Attorney-1.pdf

read more

Appointment of Ms. Karin Dorrepaal as non-executive director

May 22, 2012 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, is happy to welcome Ms. Karin Dorrepaal, PhD, MBA as its new Non-Executive Director.

Ms. Dorrepaal has been appointed at Cryo-Save’s Annual General Meeting held on May 16, 2012.

read more

EN – Appointment liquidity provider

August 6, 2010 Group News

Cryo-Save appoints Kempen & Co as liquidity provider

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, today announces that it has decided to appoint Kempen & Co as liquidity provider as of 2 August 2010.

With the appointment of a liquidity provider Cryo-Save aims to enhance the liquidity of its shares on Euronext Amsterdam.

read more

NL – Benoeming liquidity provider

August 6, 2010 Group News

Cryo-Save benoemt Kempen & Co als liquidity provider

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, maakt vandaag bekend Kempen & Co per 2 augustus 2010 te hebben benoemd als liquidity provider.

Met het aanstellen van een liquidity provider stelt Cryo-Save zich ten doel de liquiditeit van het aandeel op Euronext Amsterdam te vergroten.

read more

EN – Non-executive director appointment

March 19, 2010 Group News

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that Dr. Ronald H.W. Lorijn will be appointed as Non-Executive Director with effect from Cryo-Save’s AGM, which is expected to be on 19 May 2010, subject to shareholder approval.

read more

NL – Non-executive director appointment

March 19, 2010 Group News

Cryo-Save benoemt Ronald Lorijn tot Non-Executive director

Cryo-Save Group N.V. (AIM/Euronext: CRYO), Europa’s grootste stamcelbank, maakt bekend dat dr. Ronald H.W. Lorijn (58) (MD, PhD, MBA) tijdens de komende Algemene Vergadering van Aandeelhouders van de onderneming op 19 mei aanstaande zal worden voorgedragen voor benoeming tot Non-Executive Director en lid van de Board van Cryo-Save Group.

read more

EN – New CEO appointment

February 4, 2010 Group News

Arnoud van Tulder appointed Chief Executive

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, has appointed Arnoud van Tulder (48) as Chief Executive Officer with effect from 1 May 2010. Arnoud, currently Chief Financial Officer of Cryo-Save, will succeed Marc Waeterschoot (60), who will remain on the Board as an Executive Director.

read more

NL – New CEO appointment

February 4, 2010 Group News

Arnoud van Tulder nieuwe CEO Cryo-Save Group

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, kondigt aan dat Arnoud van Tulder (48), momenteel Chief Financial Officer van de Groep, met ingang van 1 mei 2010 zal worden benoemd tot Chief Executive Officer. Arnoud van Tulder zal Marc Waeterschoot (60) opvolgen, die evenwel aanblijft als Executive Director in de Board of Directors.

read more